<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03208192</url>
  </required_header>
  <id_info>
    <org_study_id>MCNC 01/2017</org_study_id>
    <nct_id>NCT03208192</nct_id>
  </id_info>
  <brief_title>Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection</brief_title>
  <acronym>LLS</acronym>
  <official_title>Comparison of Hydro-dissection Versus Ultrasonic Aspirator in Division of Liver Parenchyma in Laparoscopic Resection</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Moscow Clinical Scientific Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Moscow Clinical Scientific Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Background: until now, there is no agreement about the safest and feasible method for liver&#xD;
      parenchyma transection during laparoscopic liver resection.&#xD;
&#xD;
      Study design: prospective, randomized, single-center The purpose of the study: comparison of&#xD;
      short-term results of two methods of parenchyma liver transection during laparoscopic liver&#xD;
      resection&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">February 20, 2017</start_date>
  <completion_date type="Actual">May 20, 2020</completion_date>
  <primary_completion_date type="Actual">May 20, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>two groups will be compared. Group 1: liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).&#xD;
Group 2: liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Intraoperative Blood Loss</measure>
    <time_frame>1 day</time_frame>
    <description>Absolute blood loss (ml) will be calculated as the amount of blood (collected only during the parenchyma resection) in suction the container after the subtraction of all irrigating fluids and weighing operative sponges.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Аbsolute Measurement of Blood Loss in Relation to Resection Size (ml/cm^2)</measure>
    <time_frame>1 day</time_frame>
    <description>Аbsolute measurement of blood loss in relation to resection size (ml/cm^2).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Duration of Liver Parenchyma Transaction</measure>
    <time_frame>1 day</time_frame>
    <description>Duration of liver parenchyma transaction (min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Necessity to Apply the Pringle Maneuver.</measure>
    <time_frame>1 day</time_frame>
    <description>the number of participants who needed to apply the Pringle maneuver</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The Total Duration of Pringle Maneuver.</measure>
    <time_frame>1 day</time_frame>
    <description>The total duration of Pringle maneuver (min)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital Stay (Day)</measure>
    <time_frame>up to 1 month</time_frame>
    <description>Hospital stay (day)</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Morbidity</measure>
    <time_frame>30 days</time_frame>
    <description>Morbidity according to Clavien-Dindo classification (it is advisable to activate complications class II-V). The Clavien-Dindo classification (CDC) is a standardized system for the registration of surgical complications. It consists of 7 grades (I, II, IIIa, IIIb, IVa, IVb and V). The major characteristic of the CDC system is that the severity of a complication is graded based on the type of therapy required to treat the complication. The CDC system has been validated and accepted worldwide for use in many fields of surgery. The complications that change the treatment of grade II-V.</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">68</enrollment>
  <condition>Liver Transection During Laparoscopic Liver Resection</condition>
  <arm_group>
    <arm_group_label>ErbeJet</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Misonix</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>liver transection during laparoscopic liver resection</intervention_name>
    <description>liver transection during laparoscopic liver resection</description>
    <arm_group_label>ErbeJet</arm_group_label>
    <arm_group_label>Misonix</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Patients with benign lesions (hemangioma, focal nodular hyperplasia [FNH],&#xD;
             hepatocellular adenoma, biliary cystadenoma, hydatid echinococcosis [only with total&#xD;
             pericystectomy]) and malignant tumors (colorectal cancer metastases in the liver&#xD;
             [CRLM], hepatocellular carcinoma [HCC], intrahepatic cholangiocellular carcinoma,&#xD;
             gallbladder cancer T1b-3NxMo without invasion into bile ducts and adjacent organs),&#xD;
             which involves laparoscopic segmental or major resection of the liver.&#xD;
&#xD;
          -  Gender: both, male and female&#xD;
&#xD;
          -  Minimum age 18 years&#xD;
&#xD;
          -  Maximum age: 80 years&#xD;
&#xD;
          -  ASA physical status I-IV&#xD;
&#xD;
          -  BMI up to 40 kg/m2&#xD;
&#xD;
          -  No simultaneous extrahepatic intra-abdominal procedures (bile duct resection, colon&#xD;
             resection, partial duodenum resection)&#xD;
&#xD;
          -  Total bilirubin up to 100mmol/l if jaundice presents in non-cirrhotic patients&#xD;
&#xD;
          -  If cirrhosis is present, class A and B according to CTP score&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  • Difficulty index &gt; 12 points (see below)&#xD;
&#xD;
               -  Tumor invasion of IVC or portal trunk (necessity of vascular reconstruction)&#xD;
&#xD;
               -  Repeated liver resection before laparoscopic resection (the single resection&#xD;
                  before is not a contraindication)&#xD;
&#xD;
               -  Simultaneous extra-hepatic intra-abdominal procedures (bile duct resection, colon&#xD;
                  resection etc.)&#xD;
&#xD;
               -  Age under 18 years&#xD;
&#xD;
               -  Age above 80 years&#xD;
&#xD;
               -  ASA physical status &gt;IV&#xD;
&#xD;
               -  BMI &gt; 40 kg/m2&#xD;
&#xD;
               -  Total bilirubin &gt;100mmol/l if jaundice presents in non-cirrhotic patients&#xD;
&#xD;
               -  If cirrhosis is present, class C according to CTP score&#xD;
&#xD;
               -  Persons who are incapable of giving consent&#xD;
&#xD;
               -  Pregnant or breast-feeding women&#xD;
&#xD;
               -  Patients enlisted in other studies&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mikhail Efanov, MD, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Moscow Clinical Scientific Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Moscow Clinical scientific Center</name>
      <address>
        <city>Moscow</city>
        <state>Entuziastov Shosse,86</state>
        <zip>111123</zip>
        <country>Russian Federation</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Russian Federation</country>
  </location_countries>
  <verification_date>September 2020</verification_date>
  <study_first_submitted>June 26, 2017</study_first_submitted>
  <study_first_submitted_qc>July 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">July 5, 2017</study_first_posted>
  <results_first_submitted>June 4, 2020</results_first_submitted>
  <results_first_submitted_qc>September 2, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">September 24, 2020</results_first_posted>
  <last_update_submitted>September 2, 2020</last_update_submitted>
  <last_update_submitted_qc>September 2, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">September 24, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Moscow Clinical Scientific Center</investigator_affiliation>
    <investigator_full_name>Ivan Kazakov</investigator_full_name>
    <investigator_title>Clinial Research</investigator_title>
  </responsible_party>
  <keyword>colorectal liver metastases</keyword>
  <keyword>hepatocellular carcinoma</keyword>
  <keyword>intrahepatic cholangiocellular carcinoma</keyword>
  <keyword>tumor of liver</keyword>
  <keyword>focal nodular hyperplasia liver</keyword>
  <keyword>hemangioma liver</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/92/NCT03208192/Prot_000.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Informed Consent Form</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>No</document_has_sap>
      <document_date>February 20, 2017</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/92/NCT03208192/ICF_001.pdf</document_url>
    </provided_document>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 15, 2020</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/92/NCT03208192/SAP_002.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Partipants were recruited at Moscow Clinical Scientific Center. The first participant was enrolled on Feb 2017 and the last participant was enrolled in April 2020</recruitment_details>
      <pre_assignment_details>Of 68 enrolled participants, met inlusion criteria and were randomized.</pre_assignment_details>
      <group_list>
        <group group_id="P1">
          <title>ErbeJet</title>
          <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).</description>
        </group>
        <group group_id="P2">
          <title>Misonix</title>
          <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="32"/>
                <participants group_id="P2" count="36"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>ErbeJet</title>
          <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
        </group>
        <group group_id="B2">
          <title>Misonix</title>
          <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="32"/>
            <count group_id="B2" value="36"/>
            <count group_id="B3" value="68"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="56" spread="14"/>
                    <measurement group_id="B2" value="54" spread="15"/>
                    <measurement group_id="B3" value="55" spread="14"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="20"/>
                    <measurement group_id="B2" value="21"/>
                    <measurement group_id="B3" value="41"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="15"/>
                    <measurement group_id="B3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race and Ethnicity Not Collected</title>
          <population>Race and Ethnicity were not collected from any participant.</population>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="0"/>
                    <count group_id="B2" value="0"/>
                    <count group_id="B3" value="0"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index (BMI)</title>
          <units>kg/m^2</units>
          <param>Median</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="28.4" spread="6.9"/>
                    <measurement group_id="B2" value="30" spread="5.2"/>
                    <measurement group_id="B3" value="29" spread="6.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Physical status classification system (ASA)</title>
          <description>ASA 1: A normal healthy patient. ASA 2: A patient with a mild systemic disease. ASA 3: A patient with a severe systemic disease that is not life-threatening. ASA 4: A patient with a severe systemic disease that is a constant threat to life. ASA 5: A moribund patient who is not expected to survive without the operation. The patient is not expected to survive beyond the next 24 hours without surgery. ASA 6: A brain-dead patient whose organs are being removed with the intention of transplanting them into another patient.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>ASA 1</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="3"/>
                    <measurement group_id="B2" value="4"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA 2</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="15"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="35"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>ASA 3</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Malignant/benign lesions</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <title>Malignant</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="18"/>
                    <measurement group_id="B2" value="24"/>
                    <measurement group_id="B3" value="42"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Bening</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="14"/>
                    <measurement group_id="B2" value="12"/>
                    <measurement group_id="B3" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Tumor size (mm)</title>
          <units>mm</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="71" lower_limit="18" upper_limit="211"/>
                    <measurement group_id="B2" value="51" lower_limit="16" upper_limit="165"/>
                    <measurement group_id="B3" value="61" lower_limit="16" upper_limit="211"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Postero-superior segments</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="16"/>
                    <measurement group_id="B2" value="20"/>
                    <measurement group_id="B3" value="36"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Difficulty index score (IWATE Criteria) Low\Intermediate\Advanced\Expert</title>
          <description>IWATE criteria proposed at the International Consensus Conference on Laparoscopic Liver Resection as difficulty scoring system for laparoscopic liver resection. Difficulty index includes the type of liver resection (partial resection, segmentectomy, and sectionectomy), the size and topography of the tumor, its proximity to the large vessels of the liver, the presence and stage of liver cirrhosis (CTP) and has a scale ranging from 0 to 12. Difficalty level: low 0-4, intermediate 4-6, advanced 7-9, expert 10-12.</description>
          <units>units on a scale</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <class_list>
            <class>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="B1" value="32"/>
                    <count group_id="B2" value="36"/>
                    <count group_id="B3" value="68"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="7" lower_limit="2" upper_limit="12"/>
                    <measurement group_id="B2" value="7" lower_limit="2" upper_limit="12"/>
                    <measurement group_id="B3" value="7" lower_limit="2" upper_limit="12"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Intraoperative Blood Loss</title>
        <description>Absolute blood loss (ml) will be calculated as the amount of blood (collected only during the parenchyma resection) in suction the container after the subtraction of all irrigating fluids and weighing operative sponges.</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ErbeJet</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).</description>
          </group>
          <group group_id="O2">
            <title>Misonix</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)</description>
          </group>
        </group_list>
        <measure>
          <title>Intraoperative Blood Loss</title>
          <description>Absolute blood loss (ml) will be calculated as the amount of blood (collected only during the parenchyma resection) in suction the container after the subtraction of all irrigating fluids and weighing operative sponges.</description>
          <units>ml</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="195" lower_limit="10" upper_limit="400"/>
                    <measurement group_id="O2" value="218" lower_limit="10" upper_limit="1400"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Аbsolute Measurement of Blood Loss in Relation to Resection Size (ml/cm^2)</title>
        <description>Аbsolute measurement of blood loss in relation to resection size (ml/cm^2).</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ErbeJet</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).</description>
          </group>
          <group group_id="O2">
            <title>Misonix</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)</description>
          </group>
        </group_list>
        <measure>
          <title>Аbsolute Measurement of Blood Loss in Relation to Resection Size (ml/cm^2)</title>
          <description>Аbsolute measurement of blood loss in relation to resection size (ml/cm^2).</description>
          <units>ml/cm^2</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3.9" lower_limit="0.9" upper_limit="10.6"/>
                    <measurement group_id="O2" value="5" lower_limit="0.4" upper_limit="20"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Duration of Liver Parenchyma Transaction</title>
        <description>Duration of liver parenchyma transaction (min)</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ErbeJet</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).</description>
          </group>
          <group group_id="O2">
            <title>Misonix</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)</description>
          </group>
        </group_list>
        <measure>
          <title>Duration of Liver Parenchyma Transaction</title>
          <description>Duration of liver parenchyma transaction (min)</description>
          <units>min</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="107" lower_limit="19" upper_limit="305"/>
                    <measurement group_id="O2" value="100" lower_limit="20" upper_limit="300"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Necessity to Apply the Pringle Maneuver.</title>
        <description>the number of participants who needed to apply the Pringle maneuver</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ErbeJet</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
          </group>
          <group group_id="O2">
            <title>Misonix</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
          </group>
        </group_list>
        <measure>
          <title>Necessity to Apply the Pringle Maneuver.</title>
          <description>the number of participants who needed to apply the Pringle maneuver</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15"/>
                    <measurement group_id="O2" value="21"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>The Total Duration of Pringle Maneuver.</title>
        <description>The total duration of Pringle maneuver (min)</description>
        <time_frame>1 day</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ErbeJet</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
          </group>
          <group group_id="O2">
            <title>Misonix</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
          </group>
        </group_list>
        <measure>
          <title>The Total Duration of Pringle Maneuver.</title>
          <description>The total duration of Pringle maneuver (min)</description>
          <units>min</units>
          <param>Median</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23" lower_limit="3" upper_limit="59"/>
                    <measurement group_id="O2" value="18" lower_limit="2" upper_limit="48"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Hospital Stay (Day)</title>
        <description>Hospital stay (day)</description>
        <time_frame>up to 1 month</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ErbeJet</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
          </group>
          <group group_id="O2">
            <title>Misonix</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Stay (Day)</title>
          <description>Hospital stay (day)</description>
          <units>day</units>
          <param>Mean</param>
          <dispersion>Full Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8" lower_limit="5" upper_limit="16"/>
                    <measurement group_id="O2" value="8" lower_limit="4" upper_limit="19"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Morbidity</title>
        <description>Morbidity according to Clavien-Dindo classification (it is advisable to activate complications class II-V). The Clavien-Dindo classification (CDC) is a standardized system for the registration of surgical complications. It consists of 7 grades (I, II, IIIa, IIIb, IVa, IVb and V). The major characteristic of the CDC system is that the severity of a complication is graded based on the type of therapy required to treat the complication. The CDC system has been validated and accepted worldwide for use in many fields of surgery. The complications that change the treatment of grade II-V.</description>
        <time_frame>30 days</time_frame>
        <group_list>
          <group group_id="O1">
            <title>ErbeJet</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
          </group>
          <group group_id="O2">
            <title>Misonix</title>
            <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
          </group>
        </group_list>
        <measure>
          <title>Morbidity</title>
          <description>Morbidity according to Clavien-Dindo classification (it is advisable to activate complications class II-V). The Clavien-Dindo classification (CDC) is a standardized system for the registration of surgical complications. It consists of 7 grades (I, II, IIIa, IIIb, IVa, IVb and V). The major characteristic of the CDC system is that the severity of a complication is graded based on the type of therapy required to treat the complication. The CDC system has been validated and accepted worldwide for use in many fields of surgery. The complications that change the treatment of grade II-V.</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="32"/>
                <count group_id="O2" value="36"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="2"/>
                    <measurement group_id="O2" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>30 days after the operation</time_frame>
      <desc>The definition of adverse event, used to collect adverse event information, no differs from the clinicaltrials.gov Definitions</desc>
      <group_list>
        <group group_id="E1">
          <title>ErbeJet</title>
          <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon) and water-jet dissector (ERBEJET 2).&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
        </group>
        <group group_id="E2">
          <title>Misonix</title>
          <description>liver resection using a bipolar dissector (Erbe), ultracision harmonic scalpel (Ethicon), and ultrasonic aspirator (Misonix/SonaStar Ultrasonic Surgical Aspiration System)&#xD;
liver transection during laparoscopic liver resection: liver transection during laparoscopic liver resection</description>
        </group>
      </group_list>
      <serious_events>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="36"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Hepatobiliary disorders</title>
            <event_list>
              <event>
                <sub_title>fluid accumulation</sub_title>
                <description>postoperative fluid accumulation in the area of liver resection. Percutaneous puncture treatment</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <default_assessment>Non-systematic Assessment</default_assessment>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" subjects_affected="2" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
          <category>
            <title>Surgical and medical procedures</title>
            <event_list>
              <event>
                <sub_title>fluid collection</sub_title>
                <description>liquid accumulation along the line of liver resection that required percutaneous puncture</description>
                <counts group_id="E1" events="2" subjects_affected="2" subjects_at_risk="32"/>
                <counts group_id="E2" events="2" subjects_affected="2" subjects_at_risk="36"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>an addition to the exclusion criteria specified in the design of the study, the latter were expanded due to the following position. This made it difficult to recruit patients to the study.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Mikhail Efanov, MD, PhD,</name_or_title>
      <organization>Moscow Clinical Scientific Center</organization>
      <phone>+79161058830</phone>
      <email>m.efanov@mknc.ru</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

